Pharmacotherapeutics of SARS-CoV-2 Infections

被引：5

作者：

Kevadiya, Bhavesh D. ^{[1
]}

Machhi, Jatin ^{[1
]}

Herskovitz, Jonathan ^{[1
,2
]}

Oleynikov, Maxim D. ^{[1
]}

Blomberg, Wilson R. ^{[1
]}

Bajwa, Neha ^{[3
]}

Soni, Dhruvkumar ^{[4
]}

Das, Srijanee ^{[1
,2
]}

Hasan, Mahmudul ^{[4
]}

Patel, Milankumar ^{[1
]}

Senan, Ahmed M. ^{[5
]}

Gorantla, Santhi ^{[1
]}

McMillan, JoEllyn ^{[1
]}

Edagwa, Benson ^{[1
]}

Eisenberg, Robert

Gurumurthy, Channabasavaiah B. ^{[1
]}

Reid, St Patrick M. ^{[2
]}

Punyadeera, Chamindie ^{[6
,7
,8
]}

Chang, Linda ^{[9
,10
]}

Gendelman, Howard E. ^{[1
,2
,4
]}

机构：

[1] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA

[2] Univ Nebraska Med Ctr, Coll Med, Dept Pathol & Microbiol, Omaha, NE 68198 USA

[3] Maharaja Ranjit Singh Punjab Tech Univ, Dept Pharmaceut Sci & Technol, Bathinda, PB, India

[4] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA

[5] Nanjing Agr Univ, Coll Food Sci & Technol, Glyc & Glycan Bioengn Res Ctr GGBRC, Nanjing 20095, Peoples R China

[6] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia

[7] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia

[8] Translat Res Inst, Brisbane, Qld, Australia

[9] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA

[10] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA

来源：

JOURNAL OF NEUROIMMUNE PHARMACOLOGY | 2021年 / 16卷 / 01期

基金：

美国国家卫生研究院;

关键词：

SARS-CoV-2; COVID-19; therapeutics; Antivirals; Antibodies; Vaccine; EAST RESPIRATORY SYNDROME; CORONAVIRUS; COVID-19; INHIBITORS; ACE2;

D O I：

10.1007/s11481-020-09968-x

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The COVID-19 pandemic has affected more than 38 million people world-wide by person to person transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic and preventative strategies for SARS-CoV-2 remains a significant challenge. Within the past several months, effective treatment options have emerged and now include repurposed antivirals, corticosteroids and virus-specific antibodies. The latter has included convalescence plasma and monoclonal antibodies. Complete viral eradication will be achieved through an effective, safe and preventative vaccine. To now provide a comprehensive summary for each of the pharmacotherapeutics and preventative strategies being offered or soon to be developed for SARS-CoV-2.

引用

页码：12 / 37

页数：26

共 50 条

[31] SARS-CoV-2 infections in children and young people
Felsenstein, Susanna
Hedrich, Christian M.
[J]. CLINICAL IMMUNOLOGY, 2020, 220
[32] Viral kinetics of sequential SARS-CoV-2 infections
Stephen M. Kissler
James A. Hay
Joseph R. Fauver
Christina Mack
Caroline G. Tai
Deverick J. Anderson
David D. Ho
Nathan D. Grubaugh
Yonatan H. Grad
[J]. Nature Communications, 14 (1)
[33] Viral kinetics of sequential SARS-CoV-2 infections
Kissler, Stephen M.
Hay, James A.
Fauver, Joseph R.
Mack, Christina
Tai, Caroline G.
Anderson, Deverick J.
Ho, David D.
Grubaugh, Nathan D.
Grad, Yonatan H.
[J]. NATURE COMMUNICATIONS, 2023, 14 (01)
[34] Neutralizing antibody titres in SARS-CoV-2 infections
Lau, Eric H. Y.
Tsang, Owen T. Y.
Hui, David S. C.
Kwan, Mike Y. W.
Chan, Wai-hung
Chiu, Susan S.
Ko, Ronald L. W.
Chan, Kin H.
Cheng, Samuel M. S.
Perera, Ranawaka A. P. M.
Cowling, Benjamin J.
Poon, Leo L. M.
Peiris, Malik
[J]. NATURE COMMUNICATIONS, 2021, 12 (01)
[35] Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Hacisuleyman, Ezgi
Hale, Caryn
Saito, Yuhki
Blachere, Nathalie E.
Bergh, Marissa
Conlon, Erin G.
Schaefer-Babajew, Dennis J.
DaSilva, Justin
Muecksch, Frauke
Gaebler, Christian
Lifton, Richard
Nussenzweig, Michel C.
Hatziioannou, Theodora
Bieniasz, Paul D.
Darnell, Robert B.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23): : 2212 - 2218
[36] The epidemicity index of recurrent SARS-CoV-2 infections
Mari, Lorenzo
Casagrandi, Renato
Bertuzzo, Enrico
Pasetto, Damiano
Miccoli, Stefano
Rinaldo, Andrea
Gatto, Marino
[J]. NATURE COMMUNICATIONS, 2021, 12 (01)
[37] Trends and Correlates of Breakthrough Infections With SARS-CoV-2
Yamal, Jose-Miguel
Appana, Savitri
Wang, Mengxi
Leon-Novelo, Luis
Bakota, Eric
Ye, Yuanqing
Sharma, Shreela
Morrison, Alanna C.
Marko, Dritana
Linder, Stephen H.
Rector, Alison
Jetelina, Katelyn K.
Boerwinkle, Eric
de Oliveira Otto, Marcia
[J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
[38] Cutaneous Manifestations in Patients with SARS-CoV-2 Infections
Petrakis, Vasilios
Panagopoulos, Periklis
Terzi, Irene
Papazoglou, Dimitrios
[J]. ACTA DERMATOVENEROLOGICA CROATICA, 2022, 30 (04) : 216 - 219
[39] SARS-CoV-2 infections and the autonomic nervous system
Buchhorn, R.
Willaschek, C.
Baumann, C.
[J]. MONATSSCHRIFT KINDERHEILKUNDE, 2021, 169 (07) : 645 - 648
[40] Potential zoonotic sources of SARS-CoV-2 infections
Jo, Wendy K.
de Oliveira-Filho, Edmilson Ferreira
Rasche, Andrea
Greenwood, Alex D.
Osterrieder, Klaus
Drexler, Jan Felix
[J]. TRANSBOUNDARY AND EMERGING DISEASES, 2021, 68 (04) : 1824 - 1834

← 1 2 3 4 5 →